Extremity soft tissue sarcoma: Controversial management issues

Vijay P. Khatri, James E Goodnight Jr

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Unlike common malignancies, such as breast and colorectal carcinoma, where treatment modalities can be investigated with large prospective randomized trials, such an endeavor has been hampered with soft tissue sarcomas (STS) due to its rarity. In absence of such randomized clinical trials, controversy exists with regards to numerous clinically relevant questions and clinicians are left with single institutional experiences gathered either in a retrospective or prospective fashion. Some of these frequently encountered issues in the management of STS include (1) whether poorly executed biopsies affect outcome? (2) Do all unplanned excisions require re-excisions? (3) Is MRI a superior imaging modality? (4) Whether radiation should be provided pre- or post-operatively? (5) Does extent of surgical margin influence local control? (6) Is adjuvant radiation therapy necessary for stage IIB STS? (7) Does adjuvant chemotherapy influence local control? (8) Does local recurrence influence survival? We will address these topics in this review.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalSurgical Oncology
Volume14
Issue number1
DOIs
StatePublished - Jul 2005

Fingerprint

Sarcoma
Extremities
Adjuvant Chemotherapy
Colorectal Neoplasms
Radiotherapy
Randomized Controlled Trials
Radiation
Breast Neoplasms
Biopsy
Recurrence
Neoplasms
Therapeutics
Margins of Excision

Keywords

  • Chemotherapy
  • Local recurrence
  • Radiation
  • Sarcoma
  • Surgical margin

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Extremity soft tissue sarcoma : Controversial management issues. / Khatri, Vijay P.; Goodnight Jr, James E.

In: Surgical Oncology, Vol. 14, No. 1, 07.2005, p. 1-9.

Research output: Contribution to journalArticle

@article{0350a98060af461686221aa70645c310,
title = "Extremity soft tissue sarcoma: Controversial management issues",
abstract = "Unlike common malignancies, such as breast and colorectal carcinoma, where treatment modalities can be investigated with large prospective randomized trials, such an endeavor has been hampered with soft tissue sarcomas (STS) due to its rarity. In absence of such randomized clinical trials, controversy exists with regards to numerous clinically relevant questions and clinicians are left with single institutional experiences gathered either in a retrospective or prospective fashion. Some of these frequently encountered issues in the management of STS include (1) whether poorly executed biopsies affect outcome? (2) Do all unplanned excisions require re-excisions? (3) Is MRI a superior imaging modality? (4) Whether radiation should be provided pre- or post-operatively? (5) Does extent of surgical margin influence local control? (6) Is adjuvant radiation therapy necessary for stage IIB STS? (7) Does adjuvant chemotherapy influence local control? (8) Does local recurrence influence survival? We will address these topics in this review.",
keywords = "Chemotherapy, Local recurrence, Radiation, Sarcoma, Surgical margin",
author = "Khatri, {Vijay P.} and {Goodnight Jr}, {James E}",
year = "2005",
month = "7",
doi = "10.1016/j.suronc.2004.07.002",
language = "English (US)",
volume = "14",
pages = "1--9",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Extremity soft tissue sarcoma

T2 - Controversial management issues

AU - Khatri, Vijay P.

AU - Goodnight Jr, James E

PY - 2005/7

Y1 - 2005/7

N2 - Unlike common malignancies, such as breast and colorectal carcinoma, where treatment modalities can be investigated with large prospective randomized trials, such an endeavor has been hampered with soft tissue sarcomas (STS) due to its rarity. In absence of such randomized clinical trials, controversy exists with regards to numerous clinically relevant questions and clinicians are left with single institutional experiences gathered either in a retrospective or prospective fashion. Some of these frequently encountered issues in the management of STS include (1) whether poorly executed biopsies affect outcome? (2) Do all unplanned excisions require re-excisions? (3) Is MRI a superior imaging modality? (4) Whether radiation should be provided pre- or post-operatively? (5) Does extent of surgical margin influence local control? (6) Is adjuvant radiation therapy necessary for stage IIB STS? (7) Does adjuvant chemotherapy influence local control? (8) Does local recurrence influence survival? We will address these topics in this review.

AB - Unlike common malignancies, such as breast and colorectal carcinoma, where treatment modalities can be investigated with large prospective randomized trials, such an endeavor has been hampered with soft tissue sarcomas (STS) due to its rarity. In absence of such randomized clinical trials, controversy exists with regards to numerous clinically relevant questions and clinicians are left with single institutional experiences gathered either in a retrospective or prospective fashion. Some of these frequently encountered issues in the management of STS include (1) whether poorly executed biopsies affect outcome? (2) Do all unplanned excisions require re-excisions? (3) Is MRI a superior imaging modality? (4) Whether radiation should be provided pre- or post-operatively? (5) Does extent of surgical margin influence local control? (6) Is adjuvant radiation therapy necessary for stage IIB STS? (7) Does adjuvant chemotherapy influence local control? (8) Does local recurrence influence survival? We will address these topics in this review.

KW - Chemotherapy

KW - Local recurrence

KW - Radiation

KW - Sarcoma

KW - Surgical margin

UR - http://www.scopus.com/inward/record.url?scp=15044349475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15044349475&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2004.07.002

DO - 10.1016/j.suronc.2004.07.002

M3 - Article

C2 - 15777885

AN - SCOPUS:15044349475

VL - 14

SP - 1

EP - 9

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 1

ER -